BeStock  
Stocks › Biotechnology › ODTX

Odyssey Therapeutics ODTX

US equityMarket cap rank #3291Biotechnology
$16.96 −$1.38 (-7.52%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.96 0.00%
Open$17.65
Prev close$18.34
Day range$16.46 – $18.08
Volume677.8K
Market cap$815.23M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.2x
CheapRich

Near the top of its 5-year range · 93rd percentile, 5-year average -5.9x

Price / book2.4x
CheapRich

Above its usual level · 73rd percentile, 5-year average 0.5x

#3433 of 5329 stocks by PB (1 = cheapest)

Price / sales9,293.1x
CheapRich

Around its usual level · 59th percentile, 5-year average 5,709.4x

#5138 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-9x-6x-3x1xMay '26Aug '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$22.77
Price vs. fair value-25.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.45 – 0.51 73% (pricier than usual) #3433 of 5329 (1 = cheapest)
PE -5.17 -3.90 -5.91 93% (pricier than usual) –
PS 9,293.12 – 5,709.40 59% (pricier than usual) #5138 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ODTX.

Sign in to join the discussion.

Scroll to Top